Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).

This report describes double-blind placebo-controlled trials of a new synthetic antirhinovirus drug, R61837, which showed it to be effective in suppressing colds in human volunteers challenged with rhinovirus type 9. In one trial, R61837 was given by intranasal spray six times a day, commencing 28 h...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	al-Nakib, W, Higgins, P G, Barrow, G I, Tyrrell, D A, Andries, K, Vanden Bussche, G, Taylor, N, Janssen, P A
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1989
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172472/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2543283/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.4.522
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!